|
Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous) Clinical Trials
1 actively recruiting trial across 1 location
Pittsburgh, Pennsylvania1 trial
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
AHN Cancer Institute - West Penn Hospital
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.